机译:全基因组关联研究中与乳腺癌相关的常见变异是BRCA1和BRCA2突变携带者中乳腺癌风险的修饰因子
Department of Laboratory Medicine and Pathology and;
Health Sciences Research, Mayo Clinic, Rochester, MN, USA,;
Health Sciences Research, Mayo Clinic, Rochester, MN, USA,;
Health Sciences Research, Mayo Clinic, Rochester, MN, USA,;
Health Sciences Research, Mayo Clinic, Rochester, MN, USA,;
Department of Public Health and Primary Care, Cancer Research UK Genetic Epidemiology Unit and;
Department of Oncology, University of Cambridge, Cambridge, UK,;
Department of Oncology, University of Cambridge, Cambridge, UK,;
Department of Oncology, University of Cambridge, Cambridge, UK,;
Department of Public Health and Primary Care, Cancer Research UK Genetic Epidemiology Unit and;
Department of Public Health and Primary Care, Cancer Research UK Genetic Epidemiology Unit and;
Department of Public Health and Primary Care, Cancer Research UK Genetic Epidemiology Unit and;
Department of Public Health and Primary Care, Cancer Research UK Genetic Epidemiology Unit and;
Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon/Centre Léon Bérard, Lyon, France,;
INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, Paris, France,;
Equipe labellisée LIGUE 2008, UMR5201 CNRS, Centre Léon Bérard, Université de Lyon, Lyon, France,;
INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, Paris, France,;
Department of Pathology, Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands,;
Department of Medical Oncology, Rotterdam Family Cancer Clinic, Erasmus, The Netherlands,;
Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands,;
Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia,;
Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia,;
Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany,;
Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany,;
Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany,;
Department of Obstetrics and Gynaecology, Klinikum rechts der Isar, Technical University, Munich, Germany,;
University of Pennsylvania, Philadelphia, PA, USA,;
University of Pennsylvania, Philadelphia, PA, USA,;
University of Pennsylvania, Philadelphia, PA, USA,;
Medical University of Vienna, Vienna, Austria,;
Medical University of Vienna, Vienna, Austria,;
Medical University of Vienna, Vienna, Austria,;
Medical University of Vienna, Vienna, Austria,;
Department of Laboratory Medicine and Pathology and;
Department of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic,;
Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic,;
Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium,;
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA,;
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA,;
Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, MA, USA,|Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA and;
Advanced Technology Center, National Cancer Institute, Gaithersburg, MD, USA;
Department of Public Health and Primary Care, Cancer Research UK Genetic Epidemiology Unit and;
Department of Public Health and Primary Care, Cancer Research UK Genetic Epidemiology Unit and;
机译:全基因组关联研究中与乳腺癌相关的常见变异是BRCA1和BRCA2突变携带者中乳腺癌风险的修饰因子。
机译:BRCA1和BRCA2突变携带者的乳腺癌风险与遗传变异显示鉴别等位基因表达:鉴定遗迹11Q22.3的乳腺癌风险调节剂
机译:与BRCA1和BRCA2的常见变异相关的对侧乳腺癌的风险:BRCA1 / BRCA2突变携带者状态的潜在修饰作用。
机译:BRCA1和BRCA2基因在Kabardino-Balkaria的乳腺癌中BRCA2基因的突变频率
机译:BRCA1和BRCA2突变携带者进行化学预防后的乳腺癌风险。
机译:全基因组关联研究中与乳腺癌相关的常见变异是BRCA1和BRCA2突变携带者中乳腺癌风险的修饰因子
机译:全基因组关联研究中与乳腺癌相关的常见变异是BRCA1和BRCA2突变携带者中乳腺癌风险的修饰因子